title: Effects of treatment with FK409, a nitric oxide donor, on collar-induced intimal thickening and vascular reactivity.
abstract: Intimal thickening in arteries is considered a site of predilection for atherosclerosis. In a rabbit model of early atherosclerosis, a silastic collar was placed around the carotid artery, which resulted in the formation of intimal thickening. We investigated whether the oral application of FK409 ((+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide , 10 mg kg(-1) day(-1), p.o.), a nitric oxide donor, inhibited the collar-induced intimal thickening as well as accompanying reactivity changes in rabbit carotid artery. The intimal thickening was significantly inhibited by FK409. The collar treatment increased the pD2 value of 5-hydroxytryptamine (5-HT) whereas it decreased those of phenylephrine and acetylcholine and did not significantly alter that of nitroglycerine. Maximal contractile force development in response to potassium chloride (KCl), 5-HT and phenylephrine was decreased in collared arteries. The collar did not alter the maximal relaxant effects of acetylcholine and nitroglycerine. Despite the significant reduction of intimal thickening, FK409 treatment did not affect these collar-induced modifications in vascular reactivity.
authors.affiliation: Department of Pharmacology, Faculty of Pharmacy, Ege University, Izmir, Turkey. yasam@eczacilik.ege.edu.tr
authors.forename: M
authors.initials: M
authors.lastname: Yasa
authors.forename: Z
authors.initials: Z
authors.lastname: Kerry
authors.forename: G
authors.initials: G
authors.lastname: Yetik
authors.forename: G
authors.initials: G
authors.lastname: Sevin
authors.forename: B
authors.initials: B
authors.lastname: Reel
authors.forename: N
authors.initials: N
authors.lastname: Ozdemir
authors.forename: Y
authors.initials: Y
authors.lastname: Erhan
authors.forename: L
authors.initials: L
authors.lastname: Ustünes
authors.forename: T
authors.initials: T
authors.lastname: Berkan
authors.forename: A
authors.initials: A
authors.lastname: Ozer
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002339:Carotid Arteries / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000473:pathology; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D009574:Nitro Compounds / Q000494:pharmacology*; D005996:Nitroglycerin / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects
chemical_list: D020030:Nitric Oxide Donors; D009574:Nitro Compounds; D010656:Phenylephrine; D012701:Serotonin; C061872:FK 409; D005996:Nitroglycerin; D000109:Acetylcholine